Lataa...
Metabolic Reprogramming and Predominance of Solute Carrier Genes during Acquired Enzalutamide Resistance in Prostate Cancer
Androgen deprivation therapy (ADT) is standard-of-care for advanced-stage prostate cancer, and enzalutamide (Xtandi(®), Astellas, Northbrook, IL, USA), a second generation antiandrogen, is prescribed in this clinical setting. The response to this medication is usually temporary with the rapid emerge...
Tallennettuna:
| Julkaisussa: | Cells |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7759897/ https://ncbi.nlm.nih.gov/pubmed/33255236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9122535 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|